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Objectives: To compare the safety and diagnostic efficacy of coronary computed tomogra-
phy angiography (CTA) with exercise electrocardiography (XECG) in triaging patients of low
risk acute chest pain.
Background: Noninvasive assessment of coronary stenosis by CTA may improve early and
accurate triageofpatientspresentingwithacute chest pain to the emergencydepartment (ED).
Methods: Low risk patients of possible acute coronary syndrome (ACS) were included in the
study. The patients in CTA armwith significant stenosis (50%) underwent catheterization,
while those with no or intermediate stenosis (<50%) were discharged from ED and followed
up periodically for six months for major adverse cardiovascular events (MACE). The same
protocol was applied for XECG arm. Outcomes included: safety and diagnostic efficacy.
Results: A total of 81 (41 CTA and 40 XECG) patients were enrolled. In this study CTA was
observed to be 100% sensitive and 95.7% specific in diagnosing MACE in low risk patients of
chest pain presenting to the ED, with a PPV of 94.7% and an NPV of 100%.The overall
diagnostic efficacy was 97.6%. XECG was observed to be 72.7% sensitive and 96.6% specific
in diagnosing MACE with a PPV of 88.9% and NPV of 90.3% in low risk chest pain patients
presenting to the ED. The overall diagnostic accuracy was 90%.
Conclusion: CTA is an excellent diagnostic tool in ED patients with low risk of ACS, with
minimum time delay as compared to XECG, and also is safe for triaging such patients.
Copyright © 2014, Cardiological Society of India. All rights reserved.1. Introduction
There are>8million visits to emergency departments (EDs) for
chest pain or other symptoms consistent with myocardial
ischemia annually in the United States, which makes this the5.
o.in (M. Nagori).
ociety of India. All rightssecond most frequent cause of ED encounters in adults1;
however, only a minority of these patients have a life-
threatening condition. Failure to detect acute coronary syn-
drome (ACS) and inadvertent discharge of such patients from
the EDmay exceed 2%,with a risk adjustedmortality ratio that
is nearly 2-fold that of patients hospitalized for ACS, and it isreserved.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 4 3 5e4 4 2436also associatedwith substantial liability.2 Thus, rapid, optimal
therapy for patients with ACS must be balanced against
recognition of patients with noncritical syndromes for whom
hospitalization and extensive evaluation are unnecessary,
expensive, potentially hazardous, and an ineffective use of
limited resources. To achieve this goal, most strategies have
used stress testing, with or without cardiac imaging, on the
basis of the premise that a negative result markedly reduces
the likelihood of ACS .The absence of obstructive CAD indi-
cated by computed tomography coronary angiography (CTCA)
has recently been used to confirm very low risk of ACS. We
examined performance characteristics of CTA and compared
it with exercise electrocardiogram for diagnosing or excluding
an ACS in patients presenting to the EDwith possible ischemic
chest pain and examined the relation to clinical outcome
during a 6 month follow-up period.2. Methods
2.1. Study population
The study was a prospectively planned analysis of CTA and
XECG data, collected during a 1-year period from April 2010 to
March 2011 at King George Medical University, Lucknow,
India, in which consecutive patients presenting to the EDwith
possible ischemic chest pain were considered for study in-
clusion. The standard ED protocol in the medical center tri-
ages patientswith symptoms suggestive of ACS on the basis of
American College of Cardiology/American Heart Association
2002 guidelines. The study included patients with low and
intermediate risk of ACS. Intermediate risk patients had
clinical symptoms of definite ischemic origin but without
high-risk features. Low risk patients had symptoms of un-
certain origin but compatible with possible ACS. This included
patients with recent chest discomfort at rest not entirely
typical of ischemia and free of pain when initially evaluated
and without new ECG changes or elevated biomarkers.
We necessarily excluded from the study patients with
contraindication to intravenous contrast agents (contrast al-
lergy) or elevated serum creatinine (>1.3 mg/dL for men,
>0.9 mg/dL for women), Patients with atrial fibrillation,
frequent ventricular ectopy (>10 extra systoles per minute),
patients who have documented CAD by prior invasive coro-
nary angiography or coronary CT angiography and/or patients
with coronary artery stents, prior angioplasty, or prior coro-
nary artery bypass grafts (CABG); and patients who have had
prior cardiac imaging (within the past year) with normal result
including invasive coronary angiography, coronary CT angi-
ography, or nuclear stress testing were also excluded.
2.2. Exercise electrocardiogram
A group of patients who were eligible (those with normal
baseline ECG and serum markers of myocardial necrosis, and
no clinical suspicion of pulmonary embolism, aortic dissec-
tion, or pericarditis) underwent an ED physician directed
symptom-limited treadmill exercise test (Bruce protocol)
during initial diagnostic triage. Requirements before exercise
ECG testing that should be considered in the emergencydepartment setting are 2 sets of cardiac enzymes at 4 h in-
tervals should be normal, ECG at the time of presentation, and
pre exercise 12-lead ECG shows no significant change, absence
of rest ECG abnormalities that would preclude accurate
assessment of the exercise ECG, From admission to the time
results are available from the second set of cardiac enzymes:
patient asymptomatic, lessening chest pain symptoms, or
persistent atypical symptoms and absence of ischemic chest
pain at the time of exercise testing.
The exercise ECG testing facility conform to the American
Heart Association (AHA) guidelines for clinical exercise ECG
testing laboratories.
Exercise tests without ischemic responses in patients who
fail to achieve 6 METs or who fail to achieve 85% of age-
predicted maximum heart rate should be considered incon-
clusive. Patients with a conclusively positive or negative
treadmill test were hospitalized or discharged respectively.
We examined the correlation between XECG findings and
definitive diagnosis of ACS on the basis of standard diagnostic
tests. A diagnosis of ACS was made in patients who had 1 of
the following: elevated cardiac biomarkers within 7 days of
XECG, or coronary stenoses 50% at invasive coronary angi-
ography (ICA) not explained by previously known disease. For
patients discharged from the ED, follow up by telephone was
performed the next day, 1 week after ED discharge, and after 6
months. We inquired about major adverse cardiovascular
events (MACE), defined as death, myocardial infarction, or
unplanned revascularization, and about repeat ED visits or
hospitalization for unstable angina. Overall MACE rate was
the combination of in-hospital and follow up events.3. CTA
Another group of eligible patients were included in CTA arm.
CTA scans (Brilliance 64, Philips Brilliance 64, Philips
Medical Systems, Cleveland, Ohio) were performed with
retrospective ECG gating. An oral (metoprolol 50e100 mg)
and/or intravenous (metoprolol 2.5e10 mg) B-blocker (or oral
calcium antagonist [verapamil 80 mg] in asthmatic patients)
was used to lower heart rate. Oral B-blocker was adminis-
tered when heart rate was >70 bpm 1 h before scanning .If
heart rate was still >70 bpm on arrival to the CT suite and no
medical contraindication existed, intravenous metoprolol
was added.
The coronary calcium score (Agatston score)wasmeasured
in a non-contrast-enhanced scanwhen applicable. A contrast-
enhanced scanwas then performedwith a bolus of 40e150mL
contrast medium (Ultravist 370 mg I/mL; Schering AG, Berlin,
Germany) injected into an antecubital vein at a flow rate of
5e6 mL/s, followed by a 50 mL saline chaser bolus.
Scanning was performed at 120 kV, effective tube current
600e1000 mA (higher mA in obese patients), slice collimation
64 x 0.625mmacquisition, 0.4 s gantry rotation time, and pitch
0.2. Overall scan time (aswell as breathhold)wasusually<15 s.
Total time for the CTA examination was typically 10e15 min.
All patients gave written informed consent according to a
protocol approved by the institutional review board.
Patients in whom the ED CTA showed obstructive 50%
luminal stenosis was the CTA-positive group. CTA-positive
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 4 3 5e4 4 2 437patients (provisional ACS) underwent further diagnostic
testing and observation in the hospital. The patients with
normal or non obstructive CTA scans (CTA-negative patients)
underwent additional ED observation to complete serial ECG
and measurement of biomarkers at least 6e9 h apart, and, if
they were pain free and all biomarker and ECG tests were
negative, they were discharged from the hospital. All patients
were followed up over a 6 month period.
We examined the correlation between ED CTA findings and
definitive diagnosis of ACS on the basis of standard diagnostic
tests. A diagnosis of ACS was made in patients who had 1 of
the following: elevated cardiac biomarkers within 7 days of
CTA, or coronary stenosis50% at ICA (as in TIMI 3B& FRISC 2
studies) not explained by previously known disease. For pa-
tients discharged from the ED, follow up by telephone was
performed the next day, 1 week after ED discharge, and after 6
months. We inquired about major adverse cardiovascular
events (MACE), defined as death, myocardial infarction, or
unplanned revascularization, and about repeat ED visits or
hospitalization for unstable angina. Overall MACE rate was
the combination of in-hospital and follow up events.3.1. Clinical covariates
We prospectively collected data on demographics, risk factor
profile, and clinical course in all patients. Presence of risk
factors (i.e., hypertension, hypercholesterolemia, and dia-
betes mellitus) was established from actual measurements
obtained during the hospitalization or relatedmedication use.3.2. Statistical analysis
Statistical analysis was performed with the use of SPSS 15
software package. We calculated sensitivity, specificity, and
positive and negative predictive values of CTA and XECGTable 1 e Comparison of demographic and baseline characters
S.No. Characteristic CTA (n ¼
No.
1. Age (mean ± SD) (range) 52.90 ± 8.
2. Male gender 29
3. Hypertension 20
4. Diabetes mellitus 9
5. Smoking 11
6. Dyslipidemia 3
7. Obesity (BMI 30 kg/m sq) 11
8. Sedentary lifestyle 16
9. Positive family history 2
10. Tobacco chewing 7
11. Heart rate (mean ± SD) (range) 81.73 ± 8.69 (7
12. SBP (mean ± SD) (range) 130.98 ± 19.21 (1
13 DBP (mean ± SD) (range) 80.00 ± 9.75 (7
14. S. creatinine (mean ± SD) (range) 0.89 ± 0.20 (0.
15. RBS (mean ± SD) (range) 107.83 ± 35.31 (
16. Total cholesterol (mean ± SD) (range) 151.93 ± 27.88 (1
17. HDL (mean ± SD) (range) 44.46 ± 5.82 (3
18. LDL (mean ± SD) (range) 93.95 ± 23.76 (4
19. TG (mean ± SD) (range) 142.66 ± 39.82 (
Both the groups were matched and were comparable (p > 0.05).findings for diagnosis of ACS and for prediction of MACE to 6
months of follow up. A probability value of <0.05 was consid-
ered significant for statistical testing. Demographics, tradi-
tional risk factors, clinical events, and prevalence of plaque
and stenosis as detected by coronary CTA are presented as
mean ± SD or median and interquartile range for continuous
variables and as percentages for categorical variables.
We determined the utility of coronary CTA/XECG to guide
triage decisions in the ED using 2 different analytic strategies.
To determine the accuracy of coronary CTA/XECG, we calcu-
lated conventional measures of diagnostic accuracy (sensi-
tivity, negative predictive value [NPV], specificity, and positive
predictive value [PPV]) and test-positive and -negative likeli-
hood ratios with 95% confidence intervals (CIs) based on a
binomial distribution for the absence of plaque and the
absence of significant stenosis for the detection of ACS. The
chi-square test was used to compare proportions and mea-
sures of diagnostic accuracy between groups.4. Results
4.1. Patient characteristics
A total of 81 (41 CTA and 40 XECG) patients were enrolled in
the study.
Both the arms (CTA&XECG) in this studywerematched for
demographic and other baseline characteristics and therefore
were comparable (p > 0.05) [Table 1& Graph 1].4.2. CTA results
Diagnostic accuracy: In the CTA group 19/41 (46.3%) tested
positive; 1/41 (2%) tested negative came back with chest pain
(MACE on follow up). These 20/41 underwent ICA.17 Out of 20in two study groups.
41) XECG (n ¼ 40) c2/t “p”
% No. %
91 51.20 ±0.35 (30e71) 0.839 0.404
70.7% 27 67.5% 0.099 0.753
48.8% 22 55% 0.314 0.575
22.0% 10 25% 0.105 0.746
26.8% 8 20% 0.526 0.468
7.3% 3 7.5% 0.001 0.975
26.8% 8 20.0% 0.526 0.468
39.0% 11 27.5% 1.210 0.271
4.9% 0 0% 2.001 0.157
17.1% 11 27.5% 1.274 0.259
0e110) 83.23 ± 11.32 (100e190) 0.667 0.507
00e170) 133.25 ± 18.05 (100e190) 0.549 0.585
0e110) 81.75 ± 9.03 (70e100) 0.838 0.405
6e1.4) 0.79 ± 0.13 (6e1.0) 2.763 0.007
60e190) 106.20 ± 43.59 (65e255) 0.185 0.854
08e228) 148.73 ± 26.26 (104e250) 0.532 0.596
0e54) 44.90 ± 6.65 (28e53) 0.315 0.754
6e137) 98.73 ± 26.16 (49e197) 0.860 0.392
71e230) 131.38 ± 31.37 (70e219) 1.414 0.161
Graph 1 e Comparison of baseline characters.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 4 3 5e4 4 2438(85%) were true positive, 1 out of 20 (5%) cases were true
negative, 2 out of 20 (10%) were false positive [Table 2,
Graph 2].
In our study CTA was observed to be 100% sensitive and
95.7% specific in diagnosing ACS in low to intermediate risk
patients of chest pain presenting to the ED,with a PPV of 94.7%
and an NPV of 100%. Combining angiographic and clinical
results for CTA group overall diagnostic efficacy was 97.6%
[Graph 3].
An example of how CTA images look like (as in one of the
patient in the study) in multiplanar reformat displayed as
thick slice maximum intensity projection & three dimen-
sional volume rendered format is shown in Figs. 1 and 2
respectively.5. Vessel/segmental assessment
Among the three vessels, maximum sensitivity was observed
for RCA (100%) whereas maximum specificity was observed
for LCx (91.7%). The sensitivity was minimum for LCx (66.7%)
while specificity was minimum for LAD (62.5%). Overall
maximum diagnostic efficacy was observed for RCA (94.4%)
and minimum for LAD (74.4%).
For the 10 vessel segments analyzed the, CTA was most
sensitive for proximal segments (100%) while minimum for
distal segments where it has high specificity. Diagnostic effi-
cacy of CT ranged from 61.1% (LAD Prox) to 100% (RCA distal).
The highest sensitivity was obtained for LAD Prox and RCA
Prox (100%) the minimum sensitivity was obtained for LAD
Distal and LCX Distal (0%). Maximum specificity was obtainedTable 2 e CT (n ¼ 41) & XECG (n ¼ 40).
XECG
positive
XECG
negative
CT
positive
CT
negative
MACE present 8 (20%) 3 (7.5%) 18 (44%) 0 (0%)
MACE absent 1 (2.5%) 28 (70%) 1 (2%) 22 (54%)for LAD Mid, LAD distal, LCX distal and LCX Om (100%)
whereas minimum specificity was obtained for LAD Prox
(46.2%). The positive predictive value was maximum for LAD
Mid and LCX Om (100%) whereas the minimum PPV was for
LCX Prox (33%). The negative predictive value was maximum
for LAD Prox, RCA Prox and RCA distal (100%) whereas it was
minimum for LAD Mid (68%).5.1. XECG results
5.1.1. Diagnostic accuracy
In SOC, 14 out of 40 (35%) underwent ICA, 10 cases as part of
the primary diagnostic strategy and 4 cases during the 6
month follow-up period owing to recurrent chest pain (MACE)
0.8/14 were true positive (57%), 2/14 were false positive (14%),
1/14 was true negative (7%), and 3/14 were false negative (21%)
[Table 2, Graph 2].
XECGwas observed to be 72.7% sensitive and 96.6% specific
in diagnosing MACE (in-hospital þ follow up)with a PPV of
88.9% and NPV of 90.3% in low to intermediate risk chest pain
patients presenting to the ED. Combining angiographic and
clinical results for SOC group, the overall diagnostic accuracy
was 90% [Graph 3].Graph 2 e Comparison of CT & XECG in diagnosing MACE.
Graph 3 e Diagnostic efficacy of XECG & CTA (p < 001).
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 4 3 5e4 4 2 4395.2. Duke score
There were 5/40 (12.5%) patients with Duke score 10 and
remaining 35 (87.5%) had Duke score in the range of10 to þ5.
Minimum score observed was 37 whereas maximum score
observed was þ5. It was observed that the proportion of pa-
tients with lower Duke score had more MACE as compared to
those with higher Duke score (p ¼ 0.005) [Table 3].Fig. 1 e Multiplanar reformat displayed as thick slice maximum
narrowing of <50% stenosis for a segment of approx 8 mm. Ob
more than 50 % stenosis for a segment of approx 5 mm B. RCA curv
plaque seen. Distal RCA and its branches are normal. Non dom6. Discussion
Acute chest pain prompts patients to undergo ED evaluation
to exclude acute coronary syndromes. Alarmingly, up to 8% of
patients with acute coronary syndromes are misdiagnosed
and inappropriately discharged home.3,4 Of these patients
with initially normal electrocardiograms and cardiac enzymes
(low risk), only a minority actually suffers from myocardial
ischemia.5 However, because of the consequences of failure to
diagnose acute coronary syndromes, it is standard practice to
evaluate all such patients with serial electrocardiograms and
cardiac enzymes over 8e12 h, followed by stress study. This
approach is time consuming and resource intensive. CTA has
emerged as an important tool in making a rapid diagnosis in
patients with CAD. We attempted to study its efficacy in pa-
tients with chest pain at low risk for CAD & comparing it with
standard of care i.e. exercise electrocardiogram.
A total of 81 patients of chest pain with low to intermediate
risk for ACS were studied. The demographic and other base-
line characteristics of the groups assigned to CTA (41 patients)
and SOC with exercise ECG (40 patients) were comparable
(p > 0.05).intensity projection. Distal segment of LCx shows
tuse marginal branches are normal A. Proximal LAD shows
ed, is small in caliber with normal ostea. No calcification or
inant C.
Fig. 2 e Three dimensional volume rendered format useful for anatomic overview.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 4 3 5e4 4 2440Diagnostic performance of CTA (Patient based analysis ) in
various studies is summarized in Table 4.
There has been 1 prospective randomized trial that
compared early XECG to early coronary angiography in 123
low risk patients presenting with chest pain to determine
whether a negative invasive approach reduced repeat ED
visits6. Coronary angiography detected CAD more frequently
than XECG (19% versus 7%, respectively). Although more pa-
tients in the former group proceeded to revascularization,
there was no difference in cardiac events at 1-year follow up;Table 3 e Association of Duke score with MACE.
Variable Duke
score 10
Duke score between
10 and 5
c2 p
No.
(n ¼ 5)
% No.
(n ¼ 35)
%
MACE
absent
1 20 28 80 7.900 0.005
MACE
present
4 80 7 20however, angiography lowered recidivism to the ED for chest
pain compared with the noninvasive strategy (10% versus 30%
of patients, respectively).
Because of the low risk of these patients, the small but
definite risk of complications from invasive evaluation, and
the utility of noninvasive tests, coronary angiography cannot
be considered a first step in the assessment of this group, but
there may be a role for CTA in selected patients.6.1. CTA: vessel based analysis
CTA was most sensitive in picking disease in RCA and least in
LCx. It was most specific for LCx and least for LAD. Thus
overall best diagnostic efficacy of CTA was observed for RCA
and least for LAD.
In a study by Meijboom WB et al14 sensitivity was
maximum for LADwhereas it wasmost specific to find disease
in left main.
For the 10 vessel segments analyzed, CTA was most sen-
sitive for proximal segments (100%) while being minimum for
distal segments where it had high specificity.
Table 4 e Studies of CTA in ED in low risk chest pain patients in nutshell.
First author Year n Sensitivity Specificity PPV NPV DA
Udo Hoffmann7 2006 103 77% 87% 35% 100%
Hollander8 2007 54 100% 85% 46% 100%
Michael J Gallagher10 2007 85 86% 92% 50% 99%
Rubinshtein Ronen9 2007 58 92% 76% 52% 97%
Gabija Pundziute11 2007 100 100%
Goldstein12 2007 197 100% 95%
Miller13 2008 291 85% 90% 91% 83%
W Bob Meijboom14 2008 360 99% 64% 86% 97%
Sung A Chang15 2008 268 100%
Cury RC16 2008 445 95% 86% 61% 99%
Hollander17 2009 568 100%
Hoffman18 2009 368 87% 98%
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 4 3 5e4 4 2 441The low risk study population in the CTA arm had a low
calcium score (<400 U) as well which may have contributed to
its high diagnostic accuracy.
In our study myocardial bridging was found in 4 out of 41
(10%) patients .This appears to be an important cause of non
atherosclerotic chest pain in the ED and should be kept as a
differential diagnosis.
Exercise Testing in ED has been validated by multiple
studies that included approximately 3000 patients who un-
derwent XECG after >12 h of negative observation (Table 5). No
adverse effects of early XECG were reported. The low positive
predictive value for an ACS and its variability among studies is
likely related to the differences in the study cohorts. Although
the positive predictive value is low, the number of unnec-
essary admissions is reduced.
Gianrossi et al19 investigated the variability of the reported
diagnostic accuracy of the exercise ECG for CAD by applying
meta-analysis and foundmean sensitivity of 68%, lowermean
specificity of 74%; there also was a lower predictive accuracy
of 69%. This means that ex-ECG is an inadequate diagnostic
modality for ruling out CAD 50% for patients with acute
chest pain and low risk/pre test probability of disease.Table 5e Studies of XECG in ED* includes studies inwhich resul
other forms of stress testing.
Reference No. of
patients
Positive
tests, %a
Negative
valu
Tsakonls et al78 28 18 1
Kerns et al79 32 0 1
Gibler et al80 782 1
Gomez et alc, 69 100 7 1
Zalenski et al81 224 8
Polanczyk et al82 276 24
Kirk et al83 212 13 1
Diercks et al84 747 3
Sarullo et al86 190 30
Amsterdam et al77 1000 13
Ramakrishna et al85 125 27 1
a Positive exercise ECG.
b Based on clinical follow-up or further cardiac evaluation.
c Randomized controlled trial.
Adapted from Amsterdam et al.206.2. Study limitations
An important drawback of the present studywas the relatively
short followup interval forenoughhardcardiacevents, suchas
MI and cardiac death, to happen and the limited number of
patients. Because low risk patients inherently have low event
rates and the number of patients in our studywas small, there
were fewpatientswhounderwent invasiveangiographyorhad
MACE events,making it difficult to evaluate the true incidence
of false positive and false negative CTA findings.7. Clinical implications
CTA scanning has the potential to change clinical practice
with respect to ED triage in patients with chest pain of un-
certain origin. Although the benefits of clinical and noninva-
sive testing with the use of stress testing and myocardial
scintigraphy are well established, the direct anatomic infor-
mation provided by CTA scanning may have a major impact
on ED decision making, especially in patients in whom other
tests are equivocal.ts of exercise ECG tests could be distinguished from those of
predictive
e, %b
Positive predictive
value, %b
Adverse exercise
test events
00 0
00 0
99 44 0
00 0 0
98 16 0
98 15 0
00 57 0
99 37 0
99 77 0
89 33 0
00 8 0
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 4 3 5e4 4 2442The very high negative predictive value is especially valu-
able in ruling out coronary artery disease in patients who have
a low to intermediate pre test likelihood of CAD. CTA has a
lower positive predictive value with vessel or segment-based
analysis than with patient based analysis, but the negative
predictive values are similar. These data suggest that coronary
CTA cannot supplant coronary angiography in determining
which vessels have critical coronary stenosis and need
revascularization. Coronary CTA, however, seems to be
extremely reliable in ruling out critical coronary artery disease
and excluding patients who do not require further evaluation
by invasive angiography. In fact, this strong negative predic-
tive accuracy is cited as the reason for preferentially per-
forming coronary CTA in patients who have chest pain and a
low to intermediate pre test likelihood of coronary stenosis.Conflicts of interest
All authors have none to declare.r e f e r e n c e s
1. Mc Caig LF, Burt CW. The National Hospital Ambulatory Medical
Care Survey: 2003 Emergency Department Summary. Advance
Data from Vital and Health Statistics. Centers for Disease Control
and Prevention’s National Center for Health Statistics. 2005. vol.
358.
2. Kohn MA, Kwan E, Gupta M, et al. Prevalence of acute
myocardial infarction and other serious diagnoses in patients
presenting to an urban emergency department with chest
pain. J Emerg Med. 2005;29:383e390.
3. Pope JH, Aufderheide TP, Ruthazer R, et al. Missed diagnoses
of acute cardiac ischemia in the emergency department. N
Engl J Med. 2000;342:1163e1170.
4. Lee TH, Goldman L. Evaluation of the patient with acute chest
pain. N Engl J Med. 2000;342:1187e1195.
5. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002
guideline update for the management of patients with
unstable angina and non-ST-segment elevation myocardial
infarctiondsummary article: a report of the American College
of Cardiology/American Heart Association task force on
practice guidelines (Committee on the management of
patients with unstable angina). J Am Coll Cardiol.
2002;40:1366e1374.
6. deFilippi CR, Rosanio S, Tocchi M, et al. Randomized
comparison of a strategy of predischarge coronary
angiography versus exercise testing in low-risk patients in a
chest pain unit: in-hospital and long-term outcomes. J Am Coll
Cardiol. 2001;37:2042e2049.
7. Hoffmann U, Nagurney JT, Moselewski F, et al. Coronary
multidetector computed tomography in the assessment ofpatients with acute chest pain. Circulation.
2006;114:2251e2260.
8. Hollander JE, Litt HI, Chase M, et al. Computed tomography
coronary angiography for rapid disposition of low-risk
emergency department patients with chest pain syndromes.
Acad Emerg Med. 2007;14:112e116.
9. Rubinshtein R, Halon DA, Gaspar T, et al. Usefulness of 64-
slice cardiac computed tomographic angiography for
diagnosing acute coronary syndromes and predicting clinical
outcome in emergency department patients with chest pain
of uncertain origin. Circulation. 2007;115:1762e1768.
10. Gallagher MJ, Ross MA, Raff GL, et al. The diagnostic accuracy
of 64-slice computed tomography coronary angiography
compared with stress nuclear imaging in emergency
department low-risk chest pain patients. Ann Emerg Med.
2007;49:125e136.
11. Pundziute Gabija, Schuijf JD, Jukema JW, et al. Prognostic
value of multislice computed tomography coronary
angiography in patients with known or suspected coronary
artery disease. J Am Coll Cardiol. 2007;49:62e70.
12. Goldstein JA, Gallagher MJ, O’Neill WW, et al. A randomized
controlled trial of multi-slice coronary computed tomography
for evaluation of acute chest pain. J Am Coll Cardiol.
2007;49:863e871.
13. Miller JM, Rochitte CE, Dewey M, et al. Diagnostic
performance of coronary angiography by 64-row CT. N Engl J
Med. 2008;359:2324e2336.
14. MeijboomWB, Meijs MF, Schuijf JD, et al. Diagnostic accuracy
of 64-slice computed tomography coronary angiography: a
prospective, multicenter, multivendor study. J Am Coll Cardiol.
2008;52:2135e2144.
15. Chang Sung-A, Choi Sang Il, Choi Eue-Keun, et al. Usefulness
of 64-slice multidetector computed tomography as an initial
diagnostic approach in patients with acute chest pain. Am
Heart J. 2008;156:375e383.
16. Cury RC, Feutchner G, Pena CS, et al. Acute chest pain
imaging in the emergency department with cardiac
computed tomography angiography. J Nucl Cardiol.
2008;15:564e575.
17. Hollander JE, Chang AM, Shofer FS, et al. One -year outcomes
following coronary computerized tomographic angiography
for evaluation of emergency department patients with
potential acute coronary syndrome. Acad Emerg Med.
2009;16:693e698.
18. Hoffmann U, Bamberg F, Chae CU, et al. Coronary computed
tomography angiography for early triage of patients with
acute chest pain: the Rule Out Myocardial Infarction using
Computer Assisted Tomography (ROMICAT) trial. J Am Coll
Cardiol. 2009;53:1642e1650.
19. Gianrossi R, Detrano R, Mulvihill D, et al. Exercise-induced ST
depression in the diagnosis of coronary artery disease: a
meta-analysis. Circulation. 1989;80:87e98.
20. Amsterdam EA, Kirk JD, Diercks DB, Lewis WR,
Turnipseed SD. Exercise testing in chest pain units: rationale,
implementation and results. Cardiol Clin. 2005;23:503e516.
